From: The safety of Ramadan Fasting following Percutaneous Coronary Intervention
Univariate | Multivariate | |||
---|---|---|---|---|
Odds ratio (95% CI) | P value | Adjusted odds ratio (95% CI) | P value | |
Gender | 1.352 (0.497–3.678) | 0.821 | 1.458 (0.377–5.634) | 0.585 |
DM | 5.113 (1.940–13.479) | 0.001* | 2.027 (0.550–7.469) | 0.288 |
HTN | 0.754 (0.260–2.185) | 0.523 | 0.426 (0.111–1.632) | 0.213 |
Smoking | 1.506 (0.586–3.867) | 0.769 | 1.288 (0.339–4.890) | 0.710 |
Dyslipidemia | 1.231 (0.502–3.018) | 0.912 | 1.090 (0.342–3.474) | 0.884 |
Days from index PCI to the first day of RF | 1.523 (1.105–5.308) | 0.001* | 2.302 (1.600–3.311) | 0.001* |
P2Y12 inhibitor (clopidogrel or ticagrelor) | 0.881 (0.354–2.190) | 0.802 | 0.819 (0.217–3.092) | 0.768 |
PCI cause (elective or ACS) | 2.302 (0.739–7.164) | 0.523 | 1.956 (0.376–10.173) | 0.425 |
SYNTAX score > 22 | 3.020 (1.220–7.574) | 0.014* | 2.419 (2.036–5.826) | 0.026* |
Stent type (Non-sirolimus eluting or sirolimus DES) | 1.075 (0.335–3.450) | 0.394 | 3.628 (0.831–9.324) | 0.563 |
Complex procedure (bifurcation and multiple overlapped stents) | 3.013 (1.117–8.127) | 0.001* | 1.952 (1.537–7.524) | 0.032* |